Skip to Main Content

Author Details

Chirayu Chokshi
McMaster University
2015
21
10
PMIDPaper TitleJournal TitlePublished Year
36627300Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.Nat Commun2023
37354357An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma.J Neurooncol2023
37420311Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations.Acta Neuropathol Commun2023
35017149CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.J Immunother Cancer2022
36473869Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.Nat Commun2022
36178522The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers.Acta Neuropathol2022
36368321Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma.Cancer Cell2022
36170831Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma.Cell Rep2022
34298615Advances in Immunotherapy for Adult Glioblastoma.Cancers (Basel)2021
34761232<i>In vitro</i> evaluation of CAR-T cells in patient-derived glioblastoma models.STAR Protoc2021
32464096The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma.Cell Stem Cell2020
31695152A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells.Oncogene2020
33377073A Patient-Derived Xenograft Model of Glioblastoma.STAR Protoc2020
33138032RAD51-Mediated DNA Homologous Recombination Is Independent of <i>PTEN</i> Mutational Status.Cancers (Basel)2020
31115870Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.J Neurooncol2019
28986882Introduction to Cancer Stem Cells: Past, Present, and Future.Methods Mol Biol2018
29945963Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma.Cancer Res2018
29185235Erratum to: Introduction to Cancer Stem Cells: Past, Present, and Future.Methods Mol Biol2018
27581026Development of a Patient-Derived Xenograft Model Using Brain Tumor Stem Cell Systems to Study Cancer.Methods Mol Biol2016
27875301An Intrinsically Disordered APLF Links Ku, DNA-PKcs, and XRCC4-DNA Ligase IV in an Extended Flexible Non-homologous End Joining Complex.J Biol Chem2016
26179278A phylogenomic and molecular markers based analysis of the phylum Chlamydiae: proposal to divide the class Chlamydiia into two orders, Chlamydiales and Parachlamydiales ord. nov., and emended description of the class Chlamydiia.Antonie Van Leeuwenhoek2015
  • 1 - 21 of 21

Recommended Authors

Korea University, College of Medicine
Career Start Year 2015
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 2015
Number of shared co-authors 4
University of Michigan-Ann Arbor
Career Start Year 2010
Number of shared co-authors 2
California Pacific Medical Center Research Institute
Career Start Year 2009
Number of shared co-authors 0
University of California san francisco
Career Start Year 2006
Number of shared co-authors 10
Northwestern University
Career Start Year 2005
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 2005
Number of shared co-authors 0
University of California san francisco
Career Start Year 2005
Number of shared co-authors 1
The MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 3
University of Alabama at Birmingham
Career Start Year 2004
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 2002
Number of shared co-authors 3
Lerner Research Institute, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 1
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 5
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 9
University of Illinois at Urbana-Champaign
Career Start Year 1996
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 2
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 4
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 2
Stanford University
Career Start Year 1994
Number of shared co-authors 4
University of California San Diego
Career Start Year 1992
Number of shared co-authors 3
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 10
German Cancer Research Center (DKFZ)
Career Start Year 1992
Number of shared co-authors 4
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 1
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 1
Huntsman Cancer Institute, University of Utah
Career Start Year 1990
Number of shared co-authors 5
Northwestern University Feinberg School of Medicine
Career Start Year 1988
Number of shared co-authors 1
University of California san francisco
Career Start Year 1985
Number of shared co-authors 11
National Cancer Institute
Career Start Year 1985
Number of shared co-authors 14
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 1

Collaborators

McMaster University
Co-authored papers 19
McMaster Stem Cell and Cancer Research Institute
Co-authored papers 18
University of Toronto
Co-authored papers 10
College Street, University of Toronto
Co-authored papers 8
McMaster University
Co-authored papers 6
McMaster University
Co-authored papers 4
McMaster University
Co-authored papers 4
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 3
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 2
Lerner Research Institute, Cleveland Clinic
Co-authored papers 2
University of California
Co-authored papers 2
Princess Margaret Cancer Centre
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 2
Groupe Hospitalier Universitaire Pitie-Salpetriere
Co-authored papers 2
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
The Hospital for Sick Children
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
Margaret Cancer Center
Co-authored papers 1
Co-authored papers 1
Hangzhou City University
Co-authored papers 1
McMaster University
Co-authored papers 1
Cumming School of Medicine, University of Calgary
Co-authored papers 1
Westlake University
Co-authored papers 1
Co-authored papers 1
University of Calgary, 0 Hospital Drive NW
Co-authored papers 1
McMaster University
Co-authored papers 1
Juravinski Cancer Centre
Co-authored papers 1
University of California los angeles
Co-authored papers 1
School of Pharmacy, University of Waterloo
Co-authored papers 1
The University of Calgary
Co-authored papers 1